Abstract: There are described 8-(1-aminocycloalkyl)-1,3-dialckylxantaine, their derivatives and their salts with adenosine antagonist activity. A process for the preparation of said compounds and pharmaceutical compositions containing them as antidepressant, nootropic and psychostimolant drugs are also described.
Type:
Grant
Filed:
January 22, 1993
Date of Patent:
January 3, 1995
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Abstract: The herein-described invention concerns new 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(RS)-substituted, the synthesis procedure and the relative therapeutic use as antioxidizing and radical-scavenging pharmaceuticals with mucoregulation and anti-ischemic properties.
Type:
Grant
Filed:
August 6, 1990
Date of Patent:
May 19, 1992
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Inventors:
Romolo Scuri, Mario Brufani, Stefano Ceccarelli, Patrizia De Vellis, Patrizia Giannetti, Agnese Paesano, Sergio Zanarcella
Abstract: The present invention relates to (RS)-2-(2,3-dihydro-5-hydroxy-4-,6-trimethylbenozfuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4-,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, the process for producing them and their relevant therapeutical use as mucoregulators and antio-ischemic agents.
Type:
Grant
Filed:
September 17, 1990
Date of Patent:
August 20, 1991
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Abstract: The invention concerns the use of fructose-1,6-diphosphate in botany for the formulations of compositions suited for the stimulation of the germination of dormant seeds and of the growth of stem tissues of growing plants.
Type:
Grant
Filed:
March 6, 1990
Date of Patent:
August 13, 1991
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Abstract: The present invention relates to (RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, the process for producing them and their relevant therapeutical use as mucoregulators and antiischemic agents.
Type:
Grant
Filed:
April 13, 1989
Date of Patent:
March 12, 1991
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Abstract: The present invention relates to the therapeutical use of a pharmaceutical composition of fructose 1,6-diphosphate (FDP) (sodium salt) which, intravenously administered, treats somatic and psychic manifestations caused by alcoholic intoxication.
Type:
Grant
Filed:
June 20, 1988
Date of Patent:
September 26, 1989
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Abstract: The process according to the invention provides, for the purification of FDPH.sub.4 -containing solutions, for a double chromatography combined with the molecular filtration.There are thus obtained concentrated and highly pure solutions containing fructose 1,6 diphosphate acid, which are perfectly suitable to be employed for the preparation of FDP and its salts.
Type:
Grant
Filed:
December 18, 1984
Date of Patent:
March 11, 1986
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Abstract: A ferric salt of the fructose-1,6-diphosphate is disclosed, which can be precipitated quantitatively from FDP-containing mixtures and has the formula (FDP).sub.3 Fe.sub.4. For preparing such salt, a ferric salt and an alkali are added to a fermentation broth which contains FDP, whereafter the precipitate is thoroughly water washed to remove the alkali metal salt and the washed solids are dried or frozen. The ferric salt has many advantages over the calcium salt used heretofore and no organic solvents are any more required.
Type:
Grant
Filed:
September 28, 1979
Date of Patent:
July 23, 1985
Assignee:
Biomedica Foscama Industria Chimico Farmaceutica S.p.A.
Inventors:
Giulio C. Perri, Tommaso Bianco, Beniamino Piccirilli
Abstract: A preparation of fructose-1,6-diphosphate sodium salt made of a 10% solution in apyrogenic bidistilled water, characterized by protective activity of erythrocyte membrane.
Type:
Grant
Filed:
March 9, 1981
Date of Patent:
May 15, 1984
Assignee:
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.